Class III Antiarrhythmics and Phenytoin: Teratogenicity Due to Embryonic Cardiac Dysrhythmia and Reoxygenation Damage

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|7|9|787-802

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.7, Iss.9, 2001-06, pp. : 787-802

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Embryotoxicity Screening Using Embryonic Stem Cells in vitro: Correlation to in vivo Teratogenicity

By  

Cells Tissues Organs, Vol. 165, Iss. 3-4, 1999-12 ,pp. : 203-211

Karger

Access to resources Recommend Favorite

Methaqualone/phenytoin interaction: Acute vestibulocerebellar syndrome due to phenytoin toxicity: case report

By  

Reactions Weekly, Vol. 1, Iss. 1398, 2012-01 ,pp. : 29-30

Adis International

Access to resources Recommend Favorite

Developing New Anti-Arrhythmics: Clues from the Molecular Basis of Cardiac Ryanodine Receptor (RyR2) Ca2+-Release Channel Dysfunction

By  

Current Pharmaceutical Design, Vol. 13, Iss. 31, 2007-11 ,pp. : 3195-3211

Bentham Science Publishers

Access to resources Recommend Favorite

Involvement of anion exchange in the hypoxia/reoxygenation-induced changes in pH i and [Ca 2+ ] i in cardiac myocyte

By Kawasaki H.   Otani H.   Mishima K.   Imamura H.   Inagaki C.  

European Journal of Pharmacology, Vol. 411, Iss. 1, 2001-05 ,pp. : 35-43

Elsevier

Access to resources Recommend Favorite

Ramiprilat attenuates hypoxia/reoxygenation injury to cardiac myocytes via a bradykinin-dependent mechanism

By Wall T.M.   Linseman D.A.   Hartman J.C.  

European Journal of Pharmacology, Vol. 306, Iss. 1, 1996-06 ,pp. : 165-174

Elsevier

Access to resources Recommend Favorite